Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Comparison of OCT and Fluorescein Angiographic Features of Choroidal Neovascularization Due to Age-related Macular Degeneration

Go back to Resources

Comparison of OCT and Fluorescein Angiographic Features of Choroidal Neovascularization Due to Age-related Macular Degeneration

Authors:

Location:

Go back to Resources

Community-Based Multicenter Evaluation of Subcutaneous Amifostine in International Journal of Radiation Oncology * Biology * Physics

Go back to Resources

Community-Based Multicenter Evaluation of Subcutaneous Amifostine in International Journal of Radiation Oncology * Biology * Physics

Authors:

Secondary:

Location:

Go back to Resources

Cognitive function in the Age-Related Eye Disease Study (AREDS)

Go back to Resources

Cognitive function in the Age-Related Eye Disease Study (AREDS)

Authors:

Location:

Go back to Resources

Clinical features and nature course of drusenoid pigment epithelial detachments in age-related macular degeneration

Go back to Resources

Clinical features and nature course of drusenoid pigment epithelial detachments in age-related macular degeneration

Authors:

Location:

Go back to Resources

Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study (AREDS) - A propensity score approach

Go back to Resources

Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study (AREDS) - A propensity score approach

Authors:

Location:

Go back to Resources

Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study. AREDS Report No. 13

Go back to Resources

Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study. AREDS Report No. 13

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Associations between c-reactive protein and age-related macular degeneration

Go back to Resources

Associations between c-reactive protein and age-related macular degeneration

Authors:

Location:

Go back to Resources

Association between C-Reactive Protein and Macular Degeneration

Go back to Resources

Association between C-Reactive Protein and Macular Degeneration

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Antioxidant supplementation prevents the oxidation of blood plasma cysteine/cystine redox status in elderly subjects

Go back to Resources

Antioxidant supplementation prevents the oxidation of blood plasma cysteine/cystine redox status in elderly subjects

Authors:

Location:

Go back to Resources

A Simple Clinical Scale for Estimating the Risk of Age-Related Macular Degeneration Progression

Go back to Resources

A Simple Clinical Scale for Estimating the Risk of Age-Related Macular Degeneration Progression

Authors:

Secondary:

Location:

URL:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 146
  • Page 147
  • Page 148
  • Page 149
  • Current page 150
  • Page 151
  • Page 152
  • Page 153
  • Page 154
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification